 |
0 Diseases |  |
2 Trials |
|
2 Trials |  |
86 News |  |
| «12 |
- ||||| Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
Trial initiation date: Phase II Study to Evaluate the Efficacy and Safety of Glassia (clinicaltrials.gov) - Mar 29, 2014
P2/3, N=192, Recruiting, Sponsor: Kamada, Ltd.
Initiation date: Dec 2013 --> Mar 2014
- |||||| Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
Enrollment open: Phase II Study to Evaluate the Efficacy and Safety of Glassia (clinicaltrials.gov) - Mar 29, 2014
P2/3, N=192, Recruiting, Sponsor: Kamada, Ltd.
Initiation date: Dec 2013 --> Mar 2014 Not yet recruiting --> Recruiting
- |||||||||| Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
New P2/3 trial: Phase II Study to Evaluate the Efficacy and Safety of Glassia (clinicaltrials.gov) - Dec 5, 2013
P2/3, N=192, Recruiting, Sponsor: Kamada, Ltd.
- Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
Enrollment open: Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD) (clinicaltrials.gov) - Nov 21, 2013
P1/2, N=24, Recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
Trial completion: Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus (clinicaltrials.gov) - Feb 17, 2013
P1/2, N=24, Completed, Sponsor: Kamada, Ltd.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
Trial completion: GLASSIA Infusion Rate Study (clinicaltrials.gov) - Jan 25, 2013
P4, N=30, Completed, Sponsor: Baxter Healthcare Corporation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Prolastin-C (human alpha1-proteinase inhibitor IV) / Grifols, OrphanPacific
New P2/3 trial: Safety and Efficacy of (?1Proteinase Inhibitor, ?1PI) in HIV Disease (clinicaltrials.gov) - Nov 20, 2012
P2/3, N=20, Recruiting, Sponsor: AIDS Community Research Initiative of America
- | Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
New P4 trial: GLASSIA Infusion Rate Study (clinicaltrials.gov) - Jul 25, 2012
P4, N=30, Completed, Sponsor: Baxter Healthcare Corporation
- Glassia (alpha1-proteinase inhibitor (Human)) / Kamada, Takeda
New P1/2 trial: Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD) (clinicaltrials.gov) - Jan 30, 2012
P1/2, N=24, Recruiting, Sponsor: Fred Hutchinson Cancer Research Center